J. Brantley Thrasher

8.5k citations

134 papers · 6.6k indexed · 2 hit papers · h-index 44

Pulmonary and Respiratory Medicine top 0.5%
Molecular Biology top 5%
Surgery top 2%
Oncology top 5%
Urology top 0.2%

Co-authors: Benyi Li Judd W. Moul Jeffrey M. Holzbeierlein Javier Hernández Michael S. Cookson Stephen R. Kraus Celestia S. Higano S. Larry Goldenberg
Topics: Prostate Cancer Treatment and Research (37 papers)Prostate Cancer Diagnosis and Treatment (31 papers)Bladder and Urothelial Cancer Treatments (14 papers)
Cited by: Urology Pulmonary and Respiratory Medicine Rheumatology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: United States China Canada

In The Last Decade

J. Brantley Thrasher

130 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

2007 864 citations Ian M. Thompson, J. Brantley Thrasher et al. The Journal of Urology profile →
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

2007 631 citations Michael S. Cookson, Gunnar Aus et al. The Journal of Urology profile →

Peers

Countries citing papers authored by J. Brantley Thrasher

Since Specialization

Citations

This map shows the geographic impact of J. Brantley Thrasher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Brantley Thrasher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Brantley Thrasher more than expected).

Fields of papers citing papers by J. Brantley Thrasher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Brantley Thrasher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Brantley Thrasher. The network helps show where J. Brantley Thrasher may publish in the future.

Co-authorship network of co-authors of J. Brantley Thrasher

This figure shows the co-authorship network connecting the top 25 collaborators of J. Brantley Thrasher. A scholar is included among the top collaborators of J. Brantley Thrasher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Brantley Thrasher. J. Brantley Thrasher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility of a Weight Management Program Tailored for Overweight Men with Localized Prostate Cancer – A Pilot Study 2020 ·Nutrition and Cancer ·Jill Hamilton‐Reeves,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Prabhakar Chalise,(unknown),Moben Mirza,Eugene K. Lee,Debra K. Sullivan,Jennifer R. Klemp,Christie A. Befort,William P. Parker,Heather Gibbs,Wendy Demark‐Wahnefried,J. Brantley Thrasher	9
2	Prostate MRI has value, but results are not ‘gospel’ 2017 ·J. Brantley Thrasher	0
3	Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence 2014 ·Clinical Nuclear Medicine ·Reginald Dusing,(unknown),Sue‐Min Lai,Gordon L. Grado,Jeffrey M. Holzbeierlein,J. Brantley Thrasher,(unknown),Peter J. Van Veldhuizen	13
4	Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers 2013 ·Urologic Oncology Seminars and Original Investigations ·Ruibao Chen,Xing Zeng,Ruitao Zhang,Jiaoti Huang,(unknown),Jun Yang,Jihong Liu,Ossama Tawfik,J. Brantley Thrasher,Benyi Li	60
5	Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer 2012 ·Oncology Letters ·Seema Dubey,(unknown),Jeffrey M. Holzbeierlein,Ossama Tawfik,J. Brantley Thrasher,Dev Karan	11
6	A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients 2011 ·The Journal of Urology ·Paul R. Womble,(unknown),(unknown),(unknown),J. Brantley Thrasher,Jeffrey M. Holzbeierlein	27
7	Prostate cancer: genes, environment, immunity and the use of immunotherapy 2008 ·Prostate Cancer and Prostatic Diseases ·Dev Karan,J. Brantley Thrasher,David M. Lubaroff	27
8	Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival 2007 ·Cell Death and Differentiation ·(unknown),Guanxun Cheng,Paul F. Terranova,J. Brantley Thrasher,Christie P. Thomas,(unknown)	55
9	Effects of soy phytoestrogens on the prostate 2007 ·Prostate Cancer and Prostatic Diseases ·Manlio A. Goetzl,(unknown),J. Brantley Thrasher	40
10	Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Updatebreakdown → 2007 ·The Journal of Urology ·Ian M. Thompson,J. Brantley Thrasher,Gunnar Aus,Arthur L. Burnett,Edith Canby‐Hagino,Michael S. Cookson,Anthony V. D’Amico,Roger R. Dmochowski,David T. Eton,Jeffrey D. Forman,S. Larry Goldenberg,Javier Hernández,Celestia S. Higano,Stephen R. Kraus,Judd W. Moul,Catherine M. Tangen	864
11	Conditional Akt activation promotes androgen-independent progression of prostate cancer 2006 ·Carcinogenesis ·(unknown),Andy Sun,Hyewon Youn,(unknown),Paul F. Terranova,J. Brantley Thrasher,(unknown),David M. Spencer	44
12	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers 2006 ·The Prostate ·Aijing Sun,Ossama Tawfik,Bishoy A. Gayed,J. Brantley Thrasher,(unknown),Chaoyang Li,Benyi Li	103
13	What’s New in Urology 2005 ·Journal of the American College of Surgeons ·J. Brantley Thrasher	2
14	Glycogen Synthase Kinase-3β Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer 2004 ·Endocrinology ·Xinbo Liao,J. Brantley Thrasher,J.M. Holzbeierlein,Scott M. Stanley,Benyi Li	73
15	Complications of Androgen-Deprivation Therapy for Prostate Cancer 2003 ·PubMed ·Jeffrey M. Holzbeierlein,Erik P. Castle,J. Brantley Thrasher	23
16	Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy 2003 ·Urology ·Christopher J. Kane,Christopher L. Amling,Peter A.S. Johnstone,(unknown),Raymond S. Lance,J. Brantley Thrasher,John P. Foley,Robert H. Riffenburgh,Judd W. Moul	202
17	The role of soy phytoestrogens in prostate cancer 2002 ·Urologic Clinics of North America ·Erik P. Castle,J. Brantley Thrasher	44
18	Long-term complications related to the modified Indiana pouch 2002 ·Urology ·(unknown),J. Brantley Thrasher,(unknown),(unknown),John W. Weigel	79
19	Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine 1998 ·Urologic Oncology Seminars and Original Investigations ·Raymond S. Lance,Wade K. Aldous,(unknown),J. Brantley Thrasher	7
20	Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis 1996 ·Journal of Surgical Oncology ·Bradley F. Schwartz,(unknown),Samuel J. Peretsman,Judd W. Moul,George E. Deshon,Javier Hernández,(unknown),J. Brantley Thrasher	10

About J. Brantley Thrasher

J. Brantley Thrasher is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 134 papers that have together received 6.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (31 papers) and Bladder and Urothelial Cancer Treatments (14 papers). The work is most often cited by research in Urology (950 citations), Pulmonary and Respiratory Medicine (3.2k citations) and Rheumatology (844 citations). J. Brantley Thrasher has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Benyi Li, Judd W. Moul, Jeffrey M. Holzbeierlein, Javier Hernández, Michael S. Cookson, Stephen R. Kraus, Celestia S. Higano, S. Larry Goldenberg, Edith Canby‐Hagino and Catherine M. Tangen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact